Meta-analysis of Cerebrospinal Fluid Cytokine and Tryptophan Catabolite Alterations in Psychiatric Patients: Comparisons between Schizophrenia, Bipolar Disorder, and Depression

Alexandre K. Wang, Brian J Miller

Research output: Contribution to journalArticle

36 Citations (Scopus)

Abstract

Introduction: Schizophrenia, bipolar disorder, and major depressive disorder (MDD) have all been associated with immune system dysfunction, including aberrant cerebrospinal fluid (CSF) levels of cytokines and tryptophan catabolites; however, the pattern of alterations has not been compared across disorders. We performed a meta-analysis of CSF cytokine and tryptophan catabolites in patients with these major psychiatric disorders. Methods: Articles were identified by searching Pub Med, PsycInfo, and Web of Science, and the reference lists of these studies. Results: Twenty-eight studies met the inclusion criteria (16 schizophrenia, 4 bipolar disorder, and 9 MDD). CSF levels of IL-1β and kynurenic acid were significantly increased in patients with schizophrenia and bipolar disorder compared to healthy controls (P <.001). CSF levels of IL-6 and IL-8 were significantly increased in patients with schizophrenia and MDD compared to healthy controls (P ≤.013). Discussion: There is preliminary evidence for similarities in the pattern of CSF cytokine and tryptophan catabolite alterations across major psychiatric disorders, although findings must be interpreted with caution in light of small numbers of studies/subjects. Many CSF alterations are also concordant with those in the peripheral blood, particularly for schizophrenia. Findings have important implications for our understanding of the pathophysiology and treatment of major psychiatric disorders.

Original languageEnglish (US)
Pages (from-to)75-83
Number of pages9
JournalSchizophrenia Bulletin
Volume44
Issue number1
DOIs
StatePublished - Jan 1 2018

Fingerprint

Bipolar Disorder
Tryptophan
Psychiatry
Cerebrospinal Fluid
Meta-Analysis
Schizophrenia
Cytokines
Major Depressive Disorder
Kynurenic Acid
Interleukin-8
Interleukin-1
Immune System
Interleukin-6

Keywords

  • bipolar disorder
  • cerebrospinal fluid
  • cytokines
  • inflammation
  • major depressive disorder
  • meta-analysis
  • schizophrenia

ASJC Scopus subject areas

  • Psychiatry and Mental health

Cite this

@article{8c79972ee4704dcaa12fa1464b7a07e6,
title = "Meta-analysis of Cerebrospinal Fluid Cytokine and Tryptophan Catabolite Alterations in Psychiatric Patients: Comparisons between Schizophrenia, Bipolar Disorder, and Depression",
abstract = "Introduction: Schizophrenia, bipolar disorder, and major depressive disorder (MDD) have all been associated with immune system dysfunction, including aberrant cerebrospinal fluid (CSF) levels of cytokines and tryptophan catabolites; however, the pattern of alterations has not been compared across disorders. We performed a meta-analysis of CSF cytokine and tryptophan catabolites in patients with these major psychiatric disorders. Methods: Articles were identified by searching Pub Med, PsycInfo, and Web of Science, and the reference lists of these studies. Results: Twenty-eight studies met the inclusion criteria (16 schizophrenia, 4 bipolar disorder, and 9 MDD). CSF levels of IL-1β and kynurenic acid were significantly increased in patients with schizophrenia and bipolar disorder compared to healthy controls (P <.001). CSF levels of IL-6 and IL-8 were significantly increased in patients with schizophrenia and MDD compared to healthy controls (P ≤.013). Discussion: There is preliminary evidence for similarities in the pattern of CSF cytokine and tryptophan catabolite alterations across major psychiatric disorders, although findings must be interpreted with caution in light of small numbers of studies/subjects. Many CSF alterations are also concordant with those in the peripheral blood, particularly for schizophrenia. Findings have important implications for our understanding of the pathophysiology and treatment of major psychiatric disorders.",
keywords = "bipolar disorder, cerebrospinal fluid, cytokines, inflammation, major depressive disorder, meta-analysis, schizophrenia",
author = "Wang, {Alexandre K.} and Miller, {Brian J}",
year = "2018",
month = "1",
day = "1",
doi = "10.1093/schbul/sbx035",
language = "English (US)",
volume = "44",
pages = "75--83",
journal = "Schizophrenia Bulletin",
issn = "0586-7614",
publisher = "Oxford University Press",
number = "1",

}

TY - JOUR

T1 - Meta-analysis of Cerebrospinal Fluid Cytokine and Tryptophan Catabolite Alterations in Psychiatric Patients

T2 - Comparisons between Schizophrenia, Bipolar Disorder, and Depression

AU - Wang, Alexandre K.

AU - Miller, Brian J

PY - 2018/1/1

Y1 - 2018/1/1

N2 - Introduction: Schizophrenia, bipolar disorder, and major depressive disorder (MDD) have all been associated with immune system dysfunction, including aberrant cerebrospinal fluid (CSF) levels of cytokines and tryptophan catabolites; however, the pattern of alterations has not been compared across disorders. We performed a meta-analysis of CSF cytokine and tryptophan catabolites in patients with these major psychiatric disorders. Methods: Articles were identified by searching Pub Med, PsycInfo, and Web of Science, and the reference lists of these studies. Results: Twenty-eight studies met the inclusion criteria (16 schizophrenia, 4 bipolar disorder, and 9 MDD). CSF levels of IL-1β and kynurenic acid were significantly increased in patients with schizophrenia and bipolar disorder compared to healthy controls (P <.001). CSF levels of IL-6 and IL-8 were significantly increased in patients with schizophrenia and MDD compared to healthy controls (P ≤.013). Discussion: There is preliminary evidence for similarities in the pattern of CSF cytokine and tryptophan catabolite alterations across major psychiatric disorders, although findings must be interpreted with caution in light of small numbers of studies/subjects. Many CSF alterations are also concordant with those in the peripheral blood, particularly for schizophrenia. Findings have important implications for our understanding of the pathophysiology and treatment of major psychiatric disorders.

AB - Introduction: Schizophrenia, bipolar disorder, and major depressive disorder (MDD) have all been associated with immune system dysfunction, including aberrant cerebrospinal fluid (CSF) levels of cytokines and tryptophan catabolites; however, the pattern of alterations has not been compared across disorders. We performed a meta-analysis of CSF cytokine and tryptophan catabolites in patients with these major psychiatric disorders. Methods: Articles were identified by searching Pub Med, PsycInfo, and Web of Science, and the reference lists of these studies. Results: Twenty-eight studies met the inclusion criteria (16 schizophrenia, 4 bipolar disorder, and 9 MDD). CSF levels of IL-1β and kynurenic acid were significantly increased in patients with schizophrenia and bipolar disorder compared to healthy controls (P <.001). CSF levels of IL-6 and IL-8 were significantly increased in patients with schizophrenia and MDD compared to healthy controls (P ≤.013). Discussion: There is preliminary evidence for similarities in the pattern of CSF cytokine and tryptophan catabolite alterations across major psychiatric disorders, although findings must be interpreted with caution in light of small numbers of studies/subjects. Many CSF alterations are also concordant with those in the peripheral blood, particularly for schizophrenia. Findings have important implications for our understanding of the pathophysiology and treatment of major psychiatric disorders.

KW - bipolar disorder

KW - cerebrospinal fluid

KW - cytokines

KW - inflammation

KW - major depressive disorder

KW - meta-analysis

KW - schizophrenia

UR - http://www.scopus.com/inward/record.url?scp=85021844910&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85021844910&partnerID=8YFLogxK

U2 - 10.1093/schbul/sbx035

DO - 10.1093/schbul/sbx035

M3 - Article

C2 - 28338954

AN - SCOPUS:85021844910

VL - 44

SP - 75

EP - 83

JO - Schizophrenia Bulletin

JF - Schizophrenia Bulletin

SN - 0586-7614

IS - 1

ER -